Venkaiah Naidu discusses status of indigenous COVID-19 vaccine, COVAXIN with Bharat Biotech MD and Jt MD
Vice President M. Venkaiah Naidu today discussed the status of indigenous vaccine of COVID-19, COVAXIN with the Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella and Joint Managing Director Mrs. Suchitra Ella in Hyderabad.
The discussion revolved around the status of the vaccine and the plans to make it available in India and the rest of the world. During the interaction, the Vice President stressed the importance of public private partnership in coming out with indigenous world class products and lauded the collaboration between the ICMR and Bharat Biotech.
The vaccine is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research – National Institute of Virology and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) bio-containment facility.
Recently, the Prime Minister Narendra Modi visited Bharat Biotech and reviewed the status of COVAXIN. It was followed by a visit of 70 Ambassadors and High Commissioners from several nations to Bharat Biotech facility in Hyderabad.